Company intelligence / Profile preview

PTM BIO

Chicago, Illinois, United Statesptmbio.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

PTM BIO does not have clinical results as it focuses on providing advanced proteomics services and reagents. Its technologies are widely used in academic and industry research to identify protein biomarkers and study post-translational modifications relevant to human health.

Therapeutic areas: OncologyCardiovascularNeurology
Modalities: Proteomics services (MS-based)Antibody (including monoclonal and polyclonal research antibodies)Diagnostic reagents (IVD products)
Industry: Protein Biomarker Diagnostics

Partnerships

Bruker (instrument technology partnership)Bio-Connect (distribution partner in Europe)Thermo Fisher Scientific (uses Orbitrap Astral mass spectrometer for services)Academic/government collaborations implied but not specified by name

Beyond the preview

Go deeper on PTM BIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PTM BIO.

Explore the full profile